Risk Assessment and Virological Monitoring Following an Accidental Exposure to Concentrated Sabin Poliovirus Type 3 in France, November 2018
The safe and secure containment of infectious poliovirus (PV) in facilities where live PV are handled is the condition to achieve and maintain poliomyelitis eradication. Despite precautions to minimize the risk of release of PV from such facilities to the environment, breaches of containment have al...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/8/2/331 |
id |
doaj-3bb83dfc819948d98fcd2394dd075f34 |
---|---|
record_format |
Article |
spelling |
doaj-3bb83dfc819948d98fcd2394dd075f342020-11-25T03:44:44ZengMDPI AGVaccines2076-393X2020-06-01833133110.3390/vaccines8020331Risk Assessment and Virological Monitoring Following an Accidental Exposure to Concentrated Sabin Poliovirus Type 3 in France, November 2018Marion Jeannoël0Denise Antona1Clément Lazarus2Bruno Lina3Isabelle Schuffenecker4Centre National de Référence des Entérovirus et Parechovirus, WHO National Poliovirus Laboratory, Institut des Agents Infectieux, Groupement Hospitalier Nord, Hospices Civils de Lyon, 69317 Lyon, FranceSanté Publique France, 94410 Saint Maurice, FrancePublic Health Emergency Operations Centre, Division of Surveillance and Health Security, General Directorate for Health, Ministry of Solidarity and Health, 75350 Paris, FranceCentre National de Référence des Entérovirus et Parechovirus, WHO National Poliovirus Laboratory, Institut des Agents Infectieux, Groupement Hospitalier Nord, Hospices Civils de Lyon, 69317 Lyon, FranceCentre National de Référence des Entérovirus et Parechovirus, WHO National Poliovirus Laboratory, Institut des Agents Infectieux, Groupement Hospitalier Nord, Hospices Civils de Lyon, 69317 Lyon, FranceThe safe and secure containment of infectious poliovirus (PV) in facilities where live PV are handled is the condition to achieve and maintain poliomyelitis eradication. Despite precautions to minimize the risk of release of PV from such facilities to the environment, breaches of containment have already been documented. Here, we report the management of an incident that occurred on 30 November 2018 in a French vaccine manufacturing plant. Five adequately vaccinated operators were exposed to a Sabin poliovirus type 3 (PV3) spill. A microbiological risk assessment was conducted and the operators were monitored for PV shedding. On day 5 after exposure, Sabin PV3 was detected only in the stool sample of the most exposed worker. Shedding of Sabin PV3 (as detected by viral culture) was restricted to a very short period (less than 15 days). Monitoring of this incident was an opportunity to assess the relevance of our national response plan. We concluded that the measures undertaken and reported here were appropriate and proportional.https://www.mdpi.com/2076-393X/8/2/331poliovirusincidentaccidentrisk assessmentcontainment breachGAP III |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Marion Jeannoël Denise Antona Clément Lazarus Bruno Lina Isabelle Schuffenecker |
spellingShingle |
Marion Jeannoël Denise Antona Clément Lazarus Bruno Lina Isabelle Schuffenecker Risk Assessment and Virological Monitoring Following an Accidental Exposure to Concentrated Sabin Poliovirus Type 3 in France, November 2018 Vaccines poliovirus incident accident risk assessment containment breach GAP III |
author_facet |
Marion Jeannoël Denise Antona Clément Lazarus Bruno Lina Isabelle Schuffenecker |
author_sort |
Marion Jeannoël |
title |
Risk Assessment and Virological Monitoring Following an Accidental Exposure to Concentrated Sabin Poliovirus Type 3 in France, November 2018 |
title_short |
Risk Assessment and Virological Monitoring Following an Accidental Exposure to Concentrated Sabin Poliovirus Type 3 in France, November 2018 |
title_full |
Risk Assessment and Virological Monitoring Following an Accidental Exposure to Concentrated Sabin Poliovirus Type 3 in France, November 2018 |
title_fullStr |
Risk Assessment and Virological Monitoring Following an Accidental Exposure to Concentrated Sabin Poliovirus Type 3 in France, November 2018 |
title_full_unstemmed |
Risk Assessment and Virological Monitoring Following an Accidental Exposure to Concentrated Sabin Poliovirus Type 3 in France, November 2018 |
title_sort |
risk assessment and virological monitoring following an accidental exposure to concentrated sabin poliovirus type 3 in france, november 2018 |
publisher |
MDPI AG |
series |
Vaccines |
issn |
2076-393X |
publishDate |
2020-06-01 |
description |
The safe and secure containment of infectious poliovirus (PV) in facilities where live PV are handled is the condition to achieve and maintain poliomyelitis eradication. Despite precautions to minimize the risk of release of PV from such facilities to the environment, breaches of containment have already been documented. Here, we report the management of an incident that occurred on 30 November 2018 in a French vaccine manufacturing plant. Five adequately vaccinated operators were exposed to a Sabin poliovirus type 3 (PV3) spill. A microbiological risk assessment was conducted and the operators were monitored for PV shedding. On day 5 after exposure, Sabin PV3 was detected only in the stool sample of the most exposed worker. Shedding of Sabin PV3 (as detected by viral culture) was restricted to a very short period (less than 15 days). Monitoring of this incident was an opportunity to assess the relevance of our national response plan. We concluded that the measures undertaken and reported here were appropriate and proportional. |
topic |
poliovirus incident accident risk assessment containment breach GAP III |
url |
https://www.mdpi.com/2076-393X/8/2/331 |
work_keys_str_mv |
AT marionjeannoel riskassessmentandvirologicalmonitoringfollowinganaccidentalexposuretoconcentratedsabinpoliovirustype3infrancenovember2018 AT deniseantona riskassessmentandvirologicalmonitoringfollowinganaccidentalexposuretoconcentratedsabinpoliovirustype3infrancenovember2018 AT clementlazarus riskassessmentandvirologicalmonitoringfollowinganaccidentalexposuretoconcentratedsabinpoliovirustype3infrancenovember2018 AT brunolina riskassessmentandvirologicalmonitoringfollowinganaccidentalexposuretoconcentratedsabinpoliovirustype3infrancenovember2018 AT isabelleschuffenecker riskassessmentandvirologicalmonitoringfollowinganaccidentalexposuretoconcentratedsabinpoliovirustype3infrancenovember2018 |
_version_ |
1724513043300220928 |